$7.07B
$259,000
0.0% of portfolio
1,860
Q2 2025
Added 2.31%
$303M
$35,000
0.0% of portfolio
26,566
Q2 2025
Reduced 12.03%
$1.82B
$319,000
0.0% of portfolio
3,766
Q2 2025
Reduced 6.76%
$3.09B
$734,000
0.0% of portfolio
5,561
Q2 2025
Added 6.94%
$6.33B
$276,000
0.0% of portfolio
2,395
Q2 2025
Added 5.55%
$1.18B
$429,000
0.0% of portfolio
20,452
Q2 2025
Reduced 9.72%
$12B
$2.28 Million
0.0% of portfolio
12,974
Q2 2025
Added 12.99%
$1.59B
$228,000
0.0% of portfolio
3,339
Q2 2025
New
$7.59B
$549,000
0.0% of portfolio
1,854
Q2 2025
Added 4.1%
$348M
$43,000
0.0% of portfolio
24,453
Q2 2025
Added 7.84%
$15.9B
$1.26 Million
0.0% of portfolio
13,179
Q2 2025
Reduced 7.58%
$1.84B
$247,000
0.0% of portfolio
8,855
Q2 2025
Reduced 4.6%
$1.1B
$211,000
0.0% of portfolio
80,128
Q2 2025
Added 21.36%
$114M
$140,000
0.0% of portfolio
15,107
Q2 2025
Reduced 1.57%
$3.55B
$561,000
0.0% of portfolio
20,393
Q2 2025
Added 0.82%
$4.96B
$638,000
0.0% of portfolio
5,752
Q2 2025
Added 6.42%
$3.79B
$1.03 Million
0.0% of portfolio
58,066
Q2 2025
Reduced 1.15%
$463M
$141,000
0.0% of portfolio
39,775
Q2 2025
Added 9.05%
-
$0
0.0% of portfolio
-
Q2 2025
New
$411M
$49,000
0.0% of portfolio
10,968
Q2 2025
Reduced 22.4%
$5.93B
$616,000
0.0% of portfolio
25,336
Q2 2025
Added 112.11%
$2.15B
$382,000
0.0% of portfolio
8,883
Q2 2025
Reduced 6.09%
$8.12B
$386,000
0.0% of portfolio
2,851
Q2 2025
Added 3.75%
Inhibikase Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.77B
$458,000
0.0% of portfolio
8,949
Q2 2025
Added 52.82%
$1.59B
$342,000
0.0% of portfolio
6,207
Q2 2025
Reduced 6.52%
$1.36B
$326,000
0.0% of portfolio
16,259
Q2 2025
Added 2.57%
$4.19B
$871,000
0.0% of portfolio
6,313
Q2 2025
Reduced 1.57%
$19.6B
$684,000
0.0% of portfolio
6,801
Q2 2025
Reduced 85.05%
$7.44B
$941,000
0.0% of portfolio
5,221
Q2 2025
Reduced 6.37%
$2.83B
$587,000
0.0% of portfolio
11,376
Q2 2025
Reduced 1.47%
$3.4B
$947,000
0.0% of portfolio
7,705
Q2 2025
Reduced 1.91%
$1.24B
$183,000
0.0% of portfolio
14,966
Q2 2025
Reduced 5.92%
$1.31B
$129,000
0.0% of portfolio
15,631
Q2 2025
Reduced 1.08%
$943M
$234,000
0.0% of portfolio
25,018
Q2 2025
Reduced 6.08%
$5.66B
$1.27 Million
0.0% of portfolio
22,864
Q2 2025
Added 392.86%
$9.7B
$1.6 Million
0.0% of portfolio
7,155
Q2 2025
Reduced 10.35%
$1.72B
$271,000
0.0% of portfolio
12,955
Q2 2025
Reduced 4.25%
$2.89B
$362,000
0.0% of portfolio
22,949
Q2 2025
Reduced 6.83%
$2.41B
$327,000
0.0% of portfolio
8,984
Q2 2025
Reduced 5.81%
$3.3B
$536,000
0.0% of portfolio
4,089
Q2 2025
Reduced 4.77%
$10.2B
$1.83 Million
0.0% of portfolio
74,791
Q2 2025
Added 6.86%
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.99B
$438,000
0.0% of portfolio
16,009
Q2 2025
Reduced 4.61%
$251M
$106,000
0.0% of portfolio
13,524
Q2 2025
Added 2.12%
$8.68B
$234,000
0.0% of portfolio
5,943
Q2 2025
Reduced 17.12%
$11.8B
$2.11 Million
0.0% of portfolio
49,136
Q2 2025
Added 10.12%
$350M
$111,000
0.0% of portfolio
65,041
Q2 2025
Reduced 12.39%
$5.17B
$1.01 Million
0.0% of portfolio
6,540
Q2 2025
Reduced 5.94%
$196M
$27,000
0.0% of portfolio
38,852
Q2 2025
Added 2.66%